跳至主要内容
临床试验/NCT07422012
NCT07422012尚未招募不适用

Optimization of Tacrolimus Management During Pregnancy: Modeling of Unbound and Whole Blood Tacrolimus in Pregnant Uterus Transplant Recipients

Baylor Research Institute1 个研究点 分布在 1 个国家目标入组 55 人开始时间: 2026年5月31日最近更新:
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
55
试验地点
1
主要终点
Understanding Tacrolimus Levels in Pregnancy

研究概览

简要总结

To create a formula that adjusts tacrolimus blood levels. This is needed because pregnant patients have higher levels of unbound tacrolimus. The adjusted formula will give a more accurate measure of the active drug in pregnant uterus transplant patients.

详细描述

A non-linear mixed effects model describing tacrolimus exposure in pregnant and non-pregnant subjects will be developed using prospectively collected de-identified data from pregnant uterus transplant recipients at BUMC.

The model will be analyzed to develop an estimating equation for tacrolimus unbound concentrations from whole blood concentrations, albumin and hematocrit during each trimester of pregnancy.

The estimating equation will then be applied to data from uterus transplant recipients enrolled in this study and retrospectively to uterus recipients transplanted since October 2020 to clinically validate the findings.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Uterus transplant recipient
  • 18 to 50 years of age
  • receiving tacrolimus for immunosuppression.

排除标准

  • Individuals who have not had a uterine transplant
  • individuals over 50 years old

研究组 & 干预措施

Pregnant Individuals

Individuals who had a uterus transplant that are using tacrolimus during pregnancy.

干预措施: Modeling of unbound and whole blood tacrolimus in pregnant uterus transplant recipients (Biological)

结局指标

主要结局

Understanding Tacrolimus Levels in Pregnancy

时间窗: 2nd (weeks 13-26) and 3rd (weeks 27-40) trimester of pregnancy

Develop a joint non-linear mixed effect population pharmacokinetic model describing bound and unbound tacrolimus pharmacokinetics in pregnant subjects.

次要结局

  • Adjusting Tacrolimus Blood Levels by Trimester(2nd (weeks 13-26) and 3rd (weeks 27-40) trimester of pregnancy)
  • Linking the Mixed Pharmacokinetic Model and the Equation to Adjust Whold Blood Tacrolimus Concentrations to Active Tacrolimus Levels During and After Pregnancy(1 week postpartum, 4 weeks, 5 weeks and 6 weeks postpartum)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Tacrolimus in Pregnancy | 临床试验